Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Use this CTNM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CTNM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CTNM SEC filings page. Lician reads the product cache first so this HTML stays unique to Contineum Therapeutics, Inc. Class A Common Stock even when a live quote feed is slow.
Latest cached year on this hub. Full CTNM income, balance, and cash tables.